TREATMENTS FOR BLOOD SUGAR LEVELS AND MUSCLE TISSUE OPTIMIZATION USING EXTRACORPOREAL ACOUSTIC SHOCK WAVES
20220031563 · 2022-02-03
Inventors
Cpc classification
A61H19/30
HUMAN NECESSITIES
International classification
A61H23/00
HUMAN NECESSITIES
Abstract
A method of treating red blood cells of a human patient has the steps of activating an acoustic shock wave generator or source to emit acoustic shock waves and subjecting a vascular system containing red blood cells and surrounding muscle tissue peripherally through an extremity of a patient to the acoustic shock waves by stimulating the extremity wherein the extremity is positioned within a path of the emitted shock waves and away from a geometric focal volume or point of the emitted shock waves. The methods also treat muscle tissue of aging patients, from muscle regeneration or athletes for legal performance enhancement without drugs.
Claims
1. The method of preventive shock wave therapy comprises the steps of: identifying a diabetic at risk patient, the patient having an at risk baseline blood sugar level; and subjecting the at risk extremity to shock waves to lower said baseline sugar level.
2. The method of preventive shock wave therapy of claim 1 wherein the step of identifying an at risk patient includes one or more indications of risk based on family history, genetic disposition, physical condition, or blood or extremity analysis.
3. The method of preventive shock wave therapy of claim 1 further comprises the step of testing the at risk extremity to establish measured the baseline condition pre shock wave therapy.
4. The method of preventive shock wave therapy of claim 1 further comprises the step of post shockwave therapy testing the blood sugar level for comparison to the baseline condition.
5. The method of treating red blood cells of a human patient of claim 1 wherein repeating the method periodically a plurality of times over a period of weeks to lower said baseline level of blood sugar.
6. A method of treating skeletal muscle tissue of an aging human patient comprises the steps of: activating an acoustic shock wave generator or source to emit acoustic shock waves; and subjecting surrounding muscle tissue peripherally to the acoustic shock waves by stimulating the muscle tissue wherein the muscle tissue is positioned within a path of the emitted shock waves and away from a geometric focal volume or point of the emitted shock waves.
7. The method of treating an aging human patient of claim 6 wherein the emitted shock waves are divergent or near planar.
8. The method of treating an aging human patient of claim 6 wherein the emitted shock waves are convergent having a geometric focal volume or point at a distance of at least X from the generator or source, the method further comprising positioning the extremity at a distance less than the distance X from the source.
9. The method of treating an aging human patient of claim 6 wherein the patient is exhibiting one or more impairments such as: age related skeletal muscle atrophy and sarcopenia resulting in the loss of muscle capacity and mass, progressive motor neuron degeneration, increases in fat mass, decreases in lean muscle, bone mass, and cellular environmental aberrances are commonly seen alterations of aging muscle, impairments in metabolic rate, aerobic capacity, strength and balance, functional capacity, along with emotional and cognitive distress.
10. The method of treating an aging human patient of claim 6 wherein the emitted shock waves are of a low intensity ranging from 0.10-0.12 mJ/mm.sup.2.
11. A method of treating skeletal muscle tissue of a human patient to optimize athletic performance and muscle resilience comprises the steps of: activating an acoustic shock wave generator or source to emit acoustic shock waves; and subjecting surrounding muscle tissue peripherally to the acoustic shock waves by stimulating the muscle tissue wherein the muscle tissue is positioned within a path of the emitted shock waves and away from a geometric focal volume or point of the emitted shock waves.
12. The method of treating a human patient to optimize athletic performance and muscle resilience of claim 11 wherein the emitted shock waves are divergent or near planar.
13. The method of treating a human patient to optimize athletic performance and muscle resilience of claim 11 wherein the emitted shock waves are convergent having a geometric focal volume or point at a distance of at least X from the generator or source, the method further comprising positioning the extremity at a distance less than the distance X from the source.
14. The method of treating a human patient to optimize athletic performance and muscle resilience of claim 11 wherein the patient is exhibiting one or more impairments such as: age related skeletal muscle atrophy and sarcopenia resulting in the loss of muscle capacity and mass, progressive motor neuron degeneration, increases in fat mass, decreases in lean muscle, bone mass, and cellular environmental aberrances are commonly seen alterations of aging muscle, impairments in metabolic rate, aerobic capacity, strength and balance, functional capacity, along with emotional and cognitive distress.
15. The method of treating a human patient to optimize athletic performance and muscle resilience of claim 11 wherein the emitted shock waves are of a low intensity ranging from 0.10-0.14 mJ/mm.sup.2.
16. The method of treating a human patient to optimize athletic performance and muscle resilience of claim 11 wherein the emitted shock waves cause a quick removal of lactic acid from the cells of the muscle tissue allowing quicker muscle recovery.
17. The method of treating a human patient to optimize athletic performance and muscle resilience of claim 11 wherein the treatment causes rapid recovery from muscle cramping.
18. The method of treating a human patient to optimize athletic performance and muscle resilience of claim 11 wherein the treatment is used for erectile dysfunction or penis performance enhancement.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0037] The invention will be described by way of example and with reference to the accompanying drawings in which:
[0038]
[0039]
[0040]
[0041]
[0042]
[0043]
[0044]
[0045]
[0046]
[0047]
[0048]
[0049]
[0050]
[0051]
[0052]
[0053]
[0054]
[0055]
[0056]
[0057]
[0058]
[0059]
DETAILED DESCRIPTION OF THE INVENTION
[0060] The With reference to
[0061] With reference to
[0062] With reference to
[0063] A case series by Kenneth Craig Vincent, Medical Director—Kompass Health Associates, Auckland, New Zealand, attempting to improve skeletal muscle function in the older adult population derived some interesting complimentary data. The application of shockwave treatment (SWT) utilizing a DermaGold-100 (TRT LLC, USA) not only improved muscle mass, balance, and stability across the 10 trial subjects, but simultaneously indicated that blood sugar levels of three (3) of the diabetic subjects noticed an improvement in both fasting (Table 1) and postprandial (Table 2) blood sugar levels after 3 sessions of SWT.
[0064] The treatment protocol involved the application of SWT onto the hamstrings, gastrocnemius/soleus complex, and the planter aspect of the foot. Three sessions of SWT were applied onto to each subject over a one week interval.
TABLE-US-00001 TABLE 1 Fasting Blood Sugar levels taken by patient utilizing personal glucometer. Readings are based on the daily average over each week. Wk 2 Wk 4 Wk 8 Fasting Post Post Post Blood Sugar Baseline SWT SWT SWT Subject 1 (62 yr old) 128 mg/dl 126 mg/dl 122 mg/dl 116 mg/dl Subject 2 (56 yr old) 122 mg/dl 119 mg/dl 117 mg/dl 112 mg/dl Subject 3 (58 yr old) 126 mg/dl 123 mg/dl 121 mg/dl 118 mg/dl
TABLE-US-00002 TABLE 2 Blood sugar level 2 hours postprandial levels taken by patient utilizing personal glucometer. Readings are based on the daily average over each week. Wk 2 Wk 4 Wk 8 Postprandial Post Post Post Blood Sugar Baseline SWT SWT SWT Subject 1 (62 yr old) 163 mg/dl 159 mg/dl 157 mg/dl 153 mg/dl Subject 2 (56 yr old) 158 mg/dl 158 mg/dl 155 mg/dl 150 mg/dl Subject 3 (58 yr old) 161 mg/dl 157 mg/dl 154 mg/dl 151 mg/dl
[0065] These figures suggest that the increase in skeletal muscle mass and activity would increase metabolic demand and simultaneously increase blood sugar uptake, improving both fasting and postprandial blood sugar levels in diabetic patients. It is therefore plausible to hypothesize that application of an increased number of SWT impulses over the skeletal muscle of the lower extremity could help improve the control of blood sugar levels in diabetics.
[0066] Accordingly, a periodic treatment regimen of emitting 500 or more shock wave pressure pulses, preferably about 1500 pressure pulses at a low pulse energy of 0.1 mJ/mm.sup.2 or higher up to 1.0 mJ/mm.sup.2, preferably about 0.3 to 0.5 mJ/mm.sup.2 over a period of weeks on the extremity 100 will remotely improve the patient's high baseline blood sugar levels to approach, if not achieve, normal blood sugar levels.
[0067] The following description of the proper amplitude and pressure pulse intensities of the shock waves 200 are provided below along with a description of how the shock waves actually function and have been taken from the co-pending application of the present inventors and replicated herein as described below. For the purpose of describing the shock waves 200 were used as exemplary and are intended to include all of the wave patterns discussed in
[0068] This method of treatment has the steps of, locating a treatment site, generating either convergent diffused or far-sighted focused shock waves or unfocused shock waves, of directing these shock waves to the treatment site; and applying a sufficient number of these shock waves to induce activation of one or more growth factor thereby inducing or accelerating healing.
[0069] The unfocused shock waves can be of a divergent wave pattern or near planar pattern preferably of a low peak pressure amplitude and density. Typically the energy density values range as low as 0.000001 mJ/mm.sup.2 and having a high end energy density of below 1.0 mJ/mm.sup.2, preferably 0.20 mJ/mm.sup.2 or less. The peak pressure amplitude of the positive part of the cycle should be above 1.0 and its duration is below 1-3 microseconds.
[0070] The treatment depth can vary from the surface to the full depth of the human or animal torso and the treatment site can be defined by a much larger treatment area than the 0.10-3.0 cm.sup.2 commonly produced by focused waves. The above methodology is particularly well suited for surface as well as sub-surface soft extremity treatments.
[0071] While one of the benefits of the non-invasive nature of this treatment relates to reducing patient recovery and healing time, the fact that the treatments can be delivered at dosages well below the threshold of pain means that no local or general anesthesia is typically required as a consequence of the treatment. This alone significantly reduces any risk factors or complications associated with pain management during the procedure. The treatments further can reduce the need for a regiment of chemical or drug therapies before or after exposure to this shock wave therapy. Alternatively, ESWT can be used in conjunction with chemical or drug therapies to increase the cellular response permitting an opportunity to lower dosages of such chemicals or drugs while increasing the therapeutic efficiency. This is a particularly useful tool for the physician whose patient is elderly, a smoker or with an immune system deficiency which would complicate if not make unavailable more traditional invasive surgical procedures. In fact the above methodology proposed in this patent may be the first if not only choice of treatment available for patients in this class wherein heretofore conventional procedures were deemed too risky.
[0072] A further clinical benefit of the above methodology is that the procedure can be done either as an outpatient treatment or at a doctor's office assuming the patient's condition does not otherwise require hospitalization.
[0073] The stimulation of growth factors and activation of healing acceleration is particularly valuable to elderly patients and other high risk factor subjects.
[0074] Even more striking as mentioned earlier, early prevention therapies can be employed to stimulate extremity or organ modeling to be maintained within acceptable ranges prior to a degeneration occurring. This is extremely valuable in the prevention of diabetes or heart disease for example. The methods would be to identify at risk patients based on family history or genetic disposition, physical condition, etc. and subjecting that patient to therapeutic shock wave therapy for the purpose of stimulating extremity repair effectively remodeling the patient's susceptible organ to be within accepted functional parameters. The objective being to preventively stimulate cellular extremity repairs to preemptively avoid a degenerative condition from occurring which may require invasive surgical procedures.
[0075]
[0076]
[0077]
[0078]
[0079]
[0080]
[0081] This apparatus may, in certain embodiments, be adjusted/modified/or the complete shock wave head or part of it may be exchanged so that the desired and/or optimal acoustic profile such as one having wave fronts with focused, nearly plane or divergent characteristics can be chosen.
[0082] A change of the wave front characteristics may, for example, be achieved by changing the distance of the exit acoustic window relative to the reflector, by changing the reflector geometry, by introducing certain lenses or by removing elements such as lenses that modify the waves produced by a pressure pulse/shock wave generating element. Exemplary pressure pulse/shock wave sources that can, for example, be exchanged for each other to allow an apparatus to generate waves having different wave front characteristics are described in detail below.
[0083] In certain embodiments, the change of the distance of the exit acoustic window can be accomplished by a sliding movement. However, in other embodiments of the present invention, in particular, if mechanical complex arrangements, the movement can be an exchange of mechanical elements.
[0084] In one embodiment, mechanical elements that are exchanged to achieve a change in wave front characteristics include the primary pressure pulse generating element, the focusing element, the reflecting element, the housing and the membrane. In another embodiment, the mechanical elements further include a closed fluid volume within the housing in which the pressure pulse is formed and transmitted through the exit window.
[0085] In one embodiment, the apparatus of the present invention is used in combination therapy. Here, the characteristics of waves emitted by the apparatus are switched from, for example, focused to divergent or from divergent with lower energy density to divergent with higher energy density. Thus, effects of a pressure pulse treatment can be optimized by using waves having different characteristics and/or energy densities, respectively.
[0086] While the above described universal toolbox of the present invention provides versatility, the person skilled in the art will appreciate that apparatuses that only produce waves having, for example, nearly plane characteristics, are less mechanically demanding and fulfill the requirements of many users.
[0087] As the person skilled in the art will also appreciate that embodiments shown in drawings 4A-4C and 5A-5C are independent of the generation principle and thus are valid for not only electro-hydraulic shock wave generation but also for, but not limited to, PP/SW generation based on electromagnetic, piezoceramic and ballistic principles. The pressure pulse generators may, in certain embodiments, be equipped with a water cushion that houses water which defines the path of pressure pulse waves that is, through which those waves are transmitted. In a preferred embodiment, a patient is coupled via ultrasound gel or oil to the acoustic exit window (17), which can, for example, be an acoustic transparent membrane, a water cushion, a plastic plate or a metal plate.
[0088]
[0089]
[0090]
[0091]
[0092]
[0093]
[0094]
[0095]
[0096]
[0097]
[0098] With reference to
[0099] With particular reference to
[0100] With reference to
[0101] With reference to
[0102] As shown the use of these acoustic wave forms can be used separately or in combination to achieve the desired therapeutic effect.
[0103] Furthermore such acoustic wave forms can be used in combination with drugs, chemical treatments, irradiation therapy or even physical therapy and when so combined the stimulated cells will more rapidly assist the body's natural healing response.
[0104] The present invention provides an apparatus for an effective treatment of indications, which benefit from low energy pressure pulse/shock waves having nearly plane or even divergent characteristics. For the treatment of those indications, the procedure to locate the area to which the pressure pulses/shock waves are applied often needs to be less accurate than, e.g., when kidney stones are destroyed with focused waves. In fact, sometimes the knowledge of the physique of the subject to be treated is sufficient, so that imaging devices like ultrasound, x-ray or similar, as they are known from devices used in the destruction of kidney stones, may not be required. The area of the focal point/focus volume can be enlarged by reducing the focusing or even by eliminating it all together by using an apparatus according to the present invention which produces waves having wave fronts with nearly plane or divergent characteristics.
[0105] With an unfocused wave having nearly plane wave characteristic or even divergent wave characteristics, the energy density of the wave may be or may be adjusted to be so low that side effects including pain are very minor or even do not exist at all.
[0106] In certain embodiments, the apparatus of the present invention is able to produce waves having energy density values that are below 0.1 mJ/mm.sup.2 or even as low as 0.000001 mJ/mm.sup.2 In a preferred embodiment, those low end values range between 0.1-0.001 mJ/mm.sup.2 With these low energy densities, side effects are reduced and the dose application is much more uniform. Additionally, the possibility of harming surface extremity is reduced when using an apparatus of the present invention that generates waves having nearly plane or divergent characteristics and larger transmission areas compared to apparatuses using a focused shock wave source that need to be moved around to cover the affected area. The apparatus of the present invention also may allow the user to make more precise energy density adjustments than an apparatus generating only focused shock waves, which is generally limited in terms of lowering the energy output.
[0107] The treatment of the above mentioned diabetic indications are believed to be a first time use of acoustic shock wave therapy. None of the work done to date has treated the above mentioned indications with convergent, divergent, planar or near-planar acoustic shock waves of low energy.
[0108] In another treatment therapy, extracorporeal shockwave treatments are used to improve motion integrity and independence in the aging population via the regenerative enhancement of skeletal muscle tissue. The maintenance of balance is an essential task necessary for both static and dynamic stability and motion independence. Age related skeletal muscle atrophy and sarcopenia resulting in the loss of muscle capacity and mass in the elderly negatively impacts physical capacity, daily function, quality of life, and constitutes a growing global healthcare burden. Progressive motor neuron degeneration, increases in fat mass, decreases in lean muscle, bone mass, and cellular environmental aberrances are commonly seen alterations of aging muscle. This leads to impairments in metabolic rate, aerobic capacity, strength and balance, functional capacity, along with emotional and cognitive distress all of which can be improved and the degradation reversed by the use of low energy unfocused acoustic shock waves.
[0109] Method of intervention uses low-intensity extracorporeal shockwave treatment (ESWT) ranging from 0.10-0.12 mJ/mm.sup.2 to introduce a positive biocellular response in aging skeletal muscles. This ESWT can be utilized to reverse the effects of age related skeletal muscle atrophy and sarcopenia due to regenerative enhancement stimulated by shockwaves. These regenerative enhancements target a variety of myogenic transforming and regenerative growth factors via several mechanisms such as: integrin signaling, transforming growth factor beta-1 proliferation, immune-modulations, overt and covert inflammatory regulation, and progenitor cell expression among others. Unlike most interventions that commonly target or influence a narrow spectrum of a given pathology or condition, ESWT has a much boarder spectrum of influence on human tissue, as in the instance of skeletal muscle tissue. In an initial pilot series of Ten (10) older adult subjects, the inventors found that three (3) sessions of ESWT focused on several lower extremity muscle groups helped enhance muscle regeneration, improve postural and dynamic balance, and reduce activity related fatigue, improving quality of life and emotional resilience in our subjects. This occurred interestingly at a narrow optimized energy range. While the early work on tissue shows improvement, this targeted range optimizes the response.
[0110] In a third refinement, extracorporeal shockwave treatments are used to optimize athletic performance and muscle resilience. The pathogenesis of musculoskeletal overuse syndromes have come under much discussion and is commonly accepted to be the consequence of disrepair leading to degenerative syndromes with a constellation of contributory and aberrant propagating co-factors. Despite advances in sports medicine the ability to optimize athletic performance safely while preventing injuries remains elusive and an enigma.
[0111] The treatment method of intervention Low-intensity uses extracorporeal shockwave treatment (ESWT) ranging from 0.10-0.14 mJ/mm.sup.2 to introduce a positive biocellular response in healthy actively competitive athletes to help improve muscle resilience in order to perform a given task with lest exertion due to optimized muscle output levels. These regenerative enhancements target a variety of myogenic transforming and regenerative growth factors via a unique stimulus related biomechano-transduction pathway that positively influences: integrin signaling, transforming growth factor beta-1 proliferation, immune-modulations, overt and covert inflammatory regulation, and progenitor cell expression among others. Unlike most interventions that commonly target or influence a narrow spectrum of a given pathology or condition,
[0112] ESWT has a much boarder spectrum of influence on human tissue, as in the instance of skeletal muscle tissue. In an initial pilot series of eight (8) athletic subjects, the inventors found that three (3) sessions of ESWT focused on several muscle groups helped enhance the energy output of skeletal muscles providing for economics in effort to complete and perform a given task. This further suggests that the ability to prevent overuse and fatigue related syndromes among athletes is made possible by the increased resilience and energy capacity economics influenced by ESWT in skeletal muscle tissue.
[0113] In particular with athletes, this optimized shock wave treatment can be useful to quickly remove lactic acid from cells after a workout. This leads to quicker muscle recovery. This quick recovery in combination with hydration can rapidly diminish muscle cramping in athletes. This is a legal performance enhancing therapy that can achieve the results of “banned” steroid for athletes without introducing any pharmacologically prohibited drugs or stimulants. The therapy achieves everything that steroids do, but legally.
[0114] Certain enzymes prevent the propagation and or satellite stem cells found in striated muscles. ESWT reverse the effects of those enzymes allowing for the immediate replication of striated muscle cells. Enzymes act as a “governor” of sorts limiting cell replication, ESWT removes or reduces the governor or limiting effect. Return to normal cell growth is slow versus ESWT which has an optimized cell response by achieving a rapid optimal reset of the clock. When treating healthy males for erectile dysfunction, improves vitality, increases length and girth of penis, similar to the effects of steroids on muscles. This allows not only a return to normal, better than normal. It is quite normal for adult with bad eating and exercise habits to have increased blood sugar/diabetes, as discussed, these treatments can reverse blood sugar levels to normal, reverse aging and enhance muscle tissue growth in the extremities as well as the penis.
[0115] It will be appreciated that the apparatuses and processes of the present invention can have a variety of embodiments, only a few of which are disclosed herein. It will be apparent to the artisan that other embodiments exist and do not depart from the spirit of the invention. Thus, the described embodiments are illustrative and should not be construed as restrictive